Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kunches, LM; Reinhalter, NE; Marquis, A; Coakley, E; Cohen, C; Morris, AB; Mazzullo, JM
   Tolerability of enteric-coated didanosine capsules compared with didanosine tablets in adults with HIV infection
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   L.M. Kunches et al., "Tolerability of enteric-coated didanosine capsules compared with didanosine tablets in adults with HIV infection", J ACQ IMM D, 28(2), 2001, pp. 150-153
2. Michel, MC; Neumann, HG; Mehlburger, L; Schumacher, H; Goepel, M
   Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?
   BJU INTERNATIONAL
   
   M.C. Michel et al., "Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?", BJU INT, 87(1), 2001, pp. 31-34
3. Kriegel, W; Korff, KJ; Ehrlich, JC; Lehnhardt, K; Macciocchi, A; Moresino, C; Pawlowski, C
   Double-blind study comparing the long-term efficacy of the COX-2 inhibitornimesulide and naproxen in patients with osteoarthritis
   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
   
   W. Kriegel et al., "Double-blind study comparing the long-term efficacy of the COX-2 inhibitornimesulide and naproxen in patients with osteoarthritis", INT J CL PR, 55(8), 2001, pp. 510-514
4. Vallancien, G; Pariente, P
   Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France
   PROSTATE CANCER AND PROSTATIC DISEASES
   
   G. Vallancien e P. Pariente, "Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France", PROSTATE C, 4(2), 2001, pp. 124-131
5. Dorz, S; Cognolato, S; Conforti, D; Scarso, C; Borgherini, G
   A naturalistic study on the criteria of choice of second-generation antidepressants: A comparison of venlafaxine and SSRIs in depressed inpatients
   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
   
   S. Dorz et al., "A naturalistic study on the criteria of choice of second-generation antidepressants: A comparison of venlafaxine and SSRIs in depressed inpatients", INT J PSYC, 5(3), 2001, pp. 173-178
6. Lasko, BH; Laplante, A; Hebert, D; Bonnefis-Boyer, S
   Canadian valsartan study in patients with mild-to-moderate hypertension
   BLOOD PRESSURE MONITORING
   
   B.H. Lasko et al., "Canadian valsartan study in patients with mild-to-moderate hypertension", BL PRESS M, 6(2), 2001, pp. 91-99
7. Gruffyd-Jones, K; Kies, B; Middleton, A; Mulder, LJMM; Rosjo, O; Millson, DS
   Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study
   EUROPEAN JOURNAL OF NEUROLOGY
   
   K. Gruffyd-Jones et al., "Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study", EUR J NEUR, 8(3), 2001, pp. 237-245
8. Keating, GM; Goa, KL
   Management of advanced breast cancer - Defining the role of Anastrozole
   DISEASE MANAGEMENT & HEALTH OUTCOMES
   
   G.M. Keating e K.L. Goa, "Management of advanced breast cancer - Defining the role of Anastrozole", DIS MANAG H, 9(7), 2001, pp. 385-402
9. Tarricone, R; Martelli, E; Parazzini, F; Darba, J; Le Pen, C; Rovira, J
   Economic evaluation of nimesulide versus diclofenac in the treatment of osteoarthritis in France, Italy and Spain
   CLINICAL DRUG INVESTIGATION
   
   R. Tarricone et al., "Economic evaluation of nimesulide versus diclofenac in the treatment of osteoarthritis in France, Italy and Spain", CLIN DRUG I, 21(7), 2001, pp. 453-464
10. Allain, H; Arbus, L; Schuck, S
    Efficacy and safety of zolpidem administered - 'As needed' in primary insomnia results of a double-blind, placebo-controlled study
    CLINICAL DRUG INVESTIGATION
    
    H. Allain et al., "Efficacy and safety of zolpidem administered - 'As needed' in primary insomnia results of a double-blind, placebo-controlled study", CLIN DRUG I, 21(6), 2001, pp. 391-400
11. van den Heuvel, MW; Kleijn, HJ; Peeters, PAM
    Bioequivalence trial of orally disintegrating mirtazapine tablets and conventional oral mirtazapine tablets in healthy volunteers
    CLINICAL DRUG INVESTIGATION
    
    M.W. van den Heuvel et al., "Bioequivalence trial of orally disintegrating mirtazapine tablets and conventional oral mirtazapine tablets in healthy volunteers", CLIN DRUG I, 21(6), 2001, pp. 437-442
12. Liebeskind, DS; Kasner, SE
    Neuroprotection for ischaemic stroke - An unattainable goal?
    CNS DRUGS
    
    D.S. Liebeskind e S.E. Kasner, "Neuroprotection for ischaemic stroke - An unattainable goal?", CNS DRUGS, 15(3), 2001, pp. 165-174
13. Fritze, J; Moller, HJ
    Design of clinical trials of antidepressants - Should a placebo control arm be included?
    CNS DRUGS
    
    J. Fritze e H.J. Moller, "Design of clinical trials of antidepressants - Should a placebo control arm be included?", CNS DRUGS, 15(10), 2001, pp. 755-764
14. Plosker, GL; Perry, CM; Goa, KL
    Efavirenz - A pharmacoeconomic review of its use in HIV infection
    PHARMACOECONOMICS
    
    G.L. Plosker et al., "Efavirenz - A pharmacoeconomic review of its use in HIV infection", PHARMACOECO, 19(4), 2001, pp. 421-440
15. Young, M; Plosker, GL
    Piperacillin/tazobactam - A pharmacoeconomic review of its use in moderateto severe bacterial infections
    PHARMACOECONOMICS
    
    M. Young e G.L. Plosker, "Piperacillin/tazobactam - A pharmacoeconomic review of its use in moderateto severe bacterial infections", PHARMACOECO, 19(11), 2001, pp. 1135-1175
16. Saint, F; Irani, J; Salomon, L; Debois, H; Abbou, CC; Chopin, D
    Study of the safety and efficacy of maintenance treatment with intravesical BCG instillation in the prevention of superficial bladder tumours.
    PROGRES EN UROLOGIE
    
    F. Saint et al., "Study of the safety and efficacy of maintenance treatment with intravesical BCG instillation in the prevention of superficial bladder tumours.", PROG UROL, 11(4), 2001, pp. 647-656
17. Andraghetti, A; Scalese, M
    Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques
    EUROPACE
    
    A. Andraghetti e M. Scalese, "Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques", EUROPACE, 3(1), 2001, pp. 4-9
18. Sanchez-Lacay, JA; Lewis-Fernandez, R; Goetz, D; Blanco, C; Salman, E; Davies, S; Liebowitz, M
    Open trial of nefazodone among Hispanics with major depression: Efficacy, tolerability, and adherence issues
    DEPRESSION AND ANXIETY
    
    J.A. Sanchez-Lacay et al., "Open trial of nefazodone among Hispanics with major depression: Efficacy, tolerability, and adherence issues", DEPRESS ANX, 13(3), 2001, pp. 118-124
19. Prenner, BM
    The evolution of pharmacotherapy for rhinitis and urticaria
    ALLERGY AND ASTHMA PROCEEDINGS
    
    B.M. Prenner, "The evolution of pharmacotherapy for rhinitis and urticaria", ALL ASTH P, 22(5), 2001, pp. 277-280
20. McKenna, F; Weaver, A; Fiechtner, JJ; Bello, AE; Fort, JG
    COX-2 specific inhibitors in the management of osteoarthritis of the knee:A placebo-controlled, randomized, double-blind study
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    
    F. McKenna et al., "COX-2 specific inhibitors in the management of osteoarthritis of the knee:A placebo-controlled, randomized, double-blind study", JCR-J CLIN, 7(3), 2001, pp. 151-159
21. Porsteinsson, AP; Tariot, PN; Erb, R; Cox, C; Smith, E; Jakimovich, L; Noviasky, J; Kowalski, N; Holt, CJ; Irvine, C
    Placebo-controlled study of divalproex sodium for agitation in dementia
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    
    A.P. Porsteinsson et al., "Placebo-controlled study of divalproex sodium for agitation in dementia", AM J GER PS, 9(1), 2001, pp. 58-66
22. Johnson, KA; Hulse, DA; Hart, RC; Kochevar, D; Chu, Q
    Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model ofosteoarthritis
    OSTEOARTHRITIS AND CARTILAGE
    
    K.A. Johnson et al., "Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model ofosteoarthritis", OSTEO CART, 9(1), 2001, pp. 14-21
23. Markowitz, GS; Appel, GB; Fine, PL; Fenves, AZ; Loon, NR; Jagannath, S; Kuhn, JA; Dratch, AD; D'Agati, VD
    Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    G.S. Markowitz et al., "Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate", J AM S NEPH, 12(6), 2001, pp. 1164-1172
24. Benser, ME; Walcott, GP; Killingsworth, CR; Girouard, SD; Morris, MM; Ideker, RE
    Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    
    M.E. Benser et al., "Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator", J CARD ELEC, 12(8), 2001, pp. 957-964
25. White, JB; Fotuhi, PC; Pedoto, RW; Chattipakorn, N; Rogers, JM; Ideker, RE
    Reduction in atrial defibrillation threshold by a single linear ablation lesion
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    
    J.B. White et al., "Reduction in atrial defibrillation threshold by a single linear ablation lesion", J CARD ELEC, 12(4), 2001, pp. 463-471
26. Rojas, VM; Silva, R
    Palpebral twitching in a depressed adolescent on citalopram
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    
    V.M. Rojas e R. Silva, "Palpebral twitching in a depressed adolescent on citalopram", J CH AD PSY, 11(3), 2001, pp. 295-299
27. Henrotin, Y; de Leval, X; Mathy-Hartet, M; Mouithys-Mickalad, A; Deby-Dupont, G; Dogne, JM; Delarge, J; Reginster, JY
    In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators
    INFLAMMATION RESEARCH
    
    Y. Henrotin et al., "In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators", INFLAMM RES, 50(8), 2001, pp. 391-399
28. Dequeker, J; Degner, F
    Meloxicam: new formulations and their use in rheumatology
    INFLAMMATION RESEARCH
    
    J. Dequeker e F. Degner, "Meloxicam: new formulations and their use in rheumatology", INFLAMM RES, 50, 2001, pp. S3-S4
29. Combe, B; Velicitat, P; Garzon, N; Bluhmki, E
    Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients
    INFLAMMATION RESEARCH
    
    B. Combe et al., "Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients", INFLAMM RES, 50, 2001, pp. S10-S16
30. Vidal, L; Kneer, W; Baturone, M; Sigmund, R
    Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder
    INFLAMMATION RESEARCH
    
    L. Vidal et al., "Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder", INFLAMM RES, 50, 2001, pp. S24-S29
31. Hanft, G; Turck, D; Scheuerer, S; Sigmund, R
    Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations
    INFLAMMATION RESEARCH
    
    G. Hanft et al., "Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations", INFLAMM RES, 50, 2001, pp. S35-S37
32. Bobbio-Pallavicini, E; Tacconi, F; Porta, C; Brambilla, G; Mainardi, E; Bianchessi, C; Moroni, M
    Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: A phase-II study
    ONCOLOGY REPORTS
    
    E. Bobbio-Pallavicini et al., "Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: A phase-II study", ONCOL REP, 8(1), 2001, pp. 167-171
33. Quercia, O; Rafanelli, S; Puccinelli, P; Stefanini, GF
    The safety of cluster immunotherapy with aluminium hydroxide-adsorbed honey bee venom extract
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY
    
    O. Quercia et al., "The safety of cluster immunotherapy with aluminium hydroxide-adsorbed honey bee venom extract", J INVES ALL, 11(1), 2001, pp. 27-33
34. Devuyst, G; Bogousslavsky, J
    Recent progress in drug treatment for acute ischemic stroke
    CEREBROVASCULAR DISEASES
    
    G. Devuyst e J. Bogousslavsky, "Recent progress in drug treatment for acute ischemic stroke", CEREB DIS, 11, 2001, pp. 71-79
35. Lonning, PE
    Aromatase inhibitors and inactivators in breast cancer - These potent inhibitors of oestrogen synthesis may be superior to tamoxifen
    BRITISH MEDICAL JOURNAL
    
    P.E. Lonning, "Aromatase inhibitors and inactivators in breast cancer - These potent inhibitors of oestrogen synthesis may be superior to tamoxifen", BR MED J, 323(7318), 2001, pp. 880-881
36. Poole, PJ; Black, PN
    Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review
    BRITISH MEDICAL JOURNAL
    
    P.J. Poole e P.N. Black, "Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review", BR MED J, 322(7297), 2001, pp. 1271-1274
37. Manfredi, R; Chiodo, F
    Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study
    INTERNATIONAL JOURNAL OF STD & AIDS
    
    R. Manfredi e F. Chiodo, "Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study", INT J STD A, 12(2), 2001, pp. 84-88
38. Bukofzer, S; Livesey, N
    Safety and tolerability of apomorphine SL (Uprima (R))
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
    
    S. Bukofzer e N. Livesey, "Safety and tolerability of apomorphine SL (Uprima (R))", INT J IMPOT, 13, 2001, pp. S40-S44
39. Picado, C; Valero, A
    COX-1 sparing drugs in aspirin-sensitive asthma
    CLINICAL AND EXPERIMENTAL ALLERGY
    
    C. Picado e A. Valero, "COX-1 sparing drugs in aspirin-sensitive asthma", CLIN EXP AL, 31(2), 2001, pp. 179-181
40. Storms, W; Michele, TM; Knorr, B; Noonan, G; Shapiro, G; Zhang, J; Shingo, S; Reiss, TF
    Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged >= 6 years
    CLINICAL AND EXPERIMENTAL ALLERGY
    
    W. Storms et al., "Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged >= 6 years", CLIN EXP AL, 31(1), 2001, pp. 77-87
41. Lotvall, J
    Pharmacological similarities and differences between beta(2)-agonists
    RESPIRATORY MEDICINE
    
    J. Lotvall, "Pharmacological similarities and differences between beta(2)-agonists", RESP MED, 95, 2001, pp. S7-S11
42. Pauwels, R
    Formoterol - where does it fit in the current guidelines?
    RESPIRATORY MEDICINE
    
    R. Pauwels, "Formoterol - where does it fit in the current guidelines?", RESP MED, 95, 2001, pp. S30-S34
43. Petzke, F; Radbruch, L; Sabatowski, R; Karthaus, M; Mertens, A
    Slow-release tramadol for treatment of chronic malignant pain - an open multicenter trial
    SUPPORTIVE CARE IN CANCER
    
    F. Petzke et al., "Slow-release tramadol for treatment of chronic malignant pain - an open multicenter trial", SUPP CARE C, 9(1), 2001, pp. 48-54
44. Kasper, C
    Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies
    ANNALS OF HEMATOLOGY
    
    C. Kasper, "Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies", ANN HEMATOL, 80(6), 2001, pp. 319-329
45. Holgado, R; Anaya, F; Del Castillo, D
    Angiotensin II type 1 (AT(1)) receptor antagonists in the treatment of hypertension after renal transplantation
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    R. Holgado et al., "Angiotensin II type 1 (AT(1)) receptor antagonists in the treatment of hypertension after renal transplantation", NEPH DIAL T, 16, 2001, pp. 117-120
46. Sharma, T
    Quetiapine - efficacy in different domains
    EUROPEAN NEUROPSYCHOPHARMACOLOGY
    
    T. Sharma, "Quetiapine - efficacy in different domains", EUR NEUROPS, 11, 2001, pp. 385-390
47. Rubinstein, E
    Comparative safety of the different macrolides
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    E. Rubinstein, "Comparative safety of the different macrolides", INT J ANT A, 18, 2001, pp. S71-S76
48. Feldman, C; White, H; O'Grady, J; Flitcroft, A; Briggs, A; Richards, G
    An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    C. Feldman et al., "An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia", INT J ANT A, 17(3), 2001, pp. 177-188
49. Piccart, MJ; Lamb, H; Vermorken, JB
    Current and future potential roles of the platinum drugs in the treatment of ovarian cancer
    ANNALS OF ONCOLOGY
    
    M.J. Piccart et al., "Current and future potential roles of the platinum drugs in the treatment of ovarian cancer", ANN ONCOL, 12(9), 2001, pp. 1195-1203
50. Marson, AG; Hutton, JL; Leach, JP; Castillo, S; Schmidt, D; White, S; Chaisewikul, R; Privitera, M; Chadwick, DW
    Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistantlocalization-related epilepsy: a systematic review
    EPILEPSY RESEARCH
    
    A.G. Marson et al., "Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistantlocalization-related epilepsy: a systematic review", EPILEPSY R, 46(3), 2001, pp. 259-270
51. Horiuchi, K; Endo, Y
    Fluctuation analysis of information-transfer systems with feedback confirmation channels by means of fuzzy-set-valued mapping concept
    IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES
    
    K. Horiuchi e Y. Endo, "Fluctuation analysis of information-transfer systems with feedback confirmation channels by means of fuzzy-set-valued mapping concept", IEICE T FUN, E84A(4), 2001, pp. 1042-1049
52. Gavras, HP
    Issues in hypertension: Drug tolerability and special populations
    AMERICAN JOURNAL OF HYPERTENSION
    
    H.P. Gavras, "Issues in hypertension: Drug tolerability and special populations", AM J HYPERT, 14(7), 2001, pp. 231S-236S
53. Wuorimaa, T; Dagan, R; Eskola, J; Janco, J; Ahman, H; Leroy, O; Kayhty, H
    Tolerability and immunogenicity of an eleven-valent pneumococcal conjugatevaccine healthy toddlers
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    T. Wuorimaa et al., "Tolerability and immunogenicity of an eleven-valent pneumococcal conjugatevaccine healthy toddlers", PEDIAT INF, 20(3), 2001, pp. 272-277
54. Rugino, TA; Copley, TC
    Effects of modafinil in children with attention-deficit/hyperactivity disorder: An open-label study
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    T.A. Rugino e T.C. Copley, "Effects of modafinil in children with attention-deficit/hyperactivity disorder: An open-label study", J AM A CHIL, 40(2), 2001, pp. 230-235
55. Schoenfeld, P
    An evidence-based approach to the gastrointestinal safety profile of COX-2-selective anti-inflammatories
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    
    P. Schoenfeld, "An evidence-based approach to the gastrointestinal safety profile of COX-2-selective anti-inflammatories", GASTRO CLIN, 30(4), 2001, pp. 1027
56. Verma, S; Orengo, CA; Kunik, ME; Hale, D; Molinari, VA
    Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    
    S. Verma et al., "Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients", INT J GER P, 16(2), 2001, pp. 223-227
57. Fahy, S; Lawlor, BA
    Lithium use in octogenarians
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    
    S. Fahy e B.A. Lawlor, "Lithium use in octogenarians", INT J GER P, 16(10), 2001, pp. 1000-1003
58. Trenkwalder, P
    AT(1)-receptor blocker-based combination therapy in hypertension
    BLOOD PRESSURE
    
    P. Trenkwalder, "AT(1)-receptor blocker-based combination therapy in hypertension", BLOOD PRESS, 10, 2001, pp. 18-25
59. Hansson, L
    The relationship between dose and antihypertensive effect for different AT(1)-receptor blockers
    BLOOD PRESSURE
    
    L. Hansson, "The relationship between dose and antihypertensive effect for different AT(1)-receptor blockers", BLOOD PRESS, 10, 2001, pp. 33-39
60. Waeber, B
    Achieving blood pressure targets in the management of hypertension
    BLOOD PRESSURE
    
    B. Waeber, "Achieving blood pressure targets in the management of hypertension", BLOOD PRESS, 10, 2001, pp. 6-12
61. Mancia, G
    Clinical differences among angiotensin II receptor antagonists
    BLOOD PRESSURE
    
    G. Mancia, "Clinical differences among angiotensin II receptor antagonists", BLOOD PRESS, 10, 2001, pp. 19-24
62. Chang, DM; Young, TH; Hsu, CT; Kuo, SY; Hsieh, TC
    Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis
    CLINICAL RHEUMATOLOGY
    
    D.M. Chang et al., "Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis", CLIN RHEUMA, 20(2), 2001, pp. 104-113
63. Rivas-Vazquez, RA
    Reboxetine: Refocusing on the role of norepinephrine in the treatment of depression
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    
    R.A. Rivas-Vazquez, "Reboxetine: Refocusing on the role of norepinephrine in the treatment of depression", PROF PSYCH, 32(2), 2001, pp. 211-214
64. Nabholtz, JM; Bonneterre, J; Buzdar, A; Robertson, JFR; Thurlimann, B; Steinberg, M; Webster, A; von Euler, M
    Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? Reply
    JOURNAL OF CLINICAL ONCOLOGY
    
    J.M. Nabholtz et al., "Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? Reply", J CL ONCOL, 19(9), 2001, pp. 2580-2582
65. Buzdar, AU; Brady, C; Chaudri-Ross, HA
    Letrozole in second-line therapy of advanced breast cancer: More questionsthan answers - Reply
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.U. Buzdar et al., "Letrozole in second-line therapy of advanced breast cancer: More questionsthan answers - Reply", J CL ONCOL, 19(23), 2001, pp. 4354-4355
66. Boccardo, F; Rubagotti, A; Amoroso, D; Mesiti, M; Romeo, D; Caroti, C; Farris, A; Cruciani, G; Villa, E; Schieppati, G; Mustacchi, G
    Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: Results of an Italian cooperative study
    JOURNAL OF CLINICAL ONCOLOGY
    
    F. Boccardo et al., "Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: Results of an Italian cooperative study", J CL ONCOL, 19(22), 2001, pp. 4209-4215
67. Major, P; Lortholary, A; Hon, J; Abdi, E; Mills, G; Menssen, HD; Yunus, F; Bell, R; Body, J; Quebe-Fehling, E; Seaman, J
    Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials
    JOURNAL OF CLINICAL ONCOLOGY
    
    P. Major et al., "Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials", J CL ONCOL, 19(2), 2001, pp. 558-567
68. Donnellan, PP; Douglas, SL; Cameron, DA; Leonard, RCF
    Aromatase inhibitors and arthralgia
    JOURNAL OF CLINICAL ONCOLOGY
    
    P.P. Donnellan et al., "Aromatase inhibitors and arthralgia", J CL ONCOL, 19(10), 2001, pp. 2767-2767
69. Kotzan, J; Wade, W; Yu, HH
    Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population
    PHARMACEUTICAL RESEARCH
    
    J. Kotzan et al., "Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population", PHARM RES, 18(9), 2001, pp. 1367-1372
70. Madersbacher, H; Murtz, G
    Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)
    WORLD JOURNAL OF UROLOGY
    
    H. Madersbacher e G. Murtz, "Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)", WORLD J URO, 19(5), 2001, pp. 324-335
71. Farker, K; Naber, KG; Funfstuck, R
    Fluoroquinolones: Treatment of urinary tract infections
    MEDIZINISCHE KLINIK
    
    K. Farker et al., "Fluoroquinolones: Treatment of urinary tract infections", MED KLIN, 96(7), 2001, pp. 383-390
72. Hawkey, CJ
    NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials?The gastroenterologist's perspective
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    C.J. Hawkey, "NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials?The gastroenterologist's perspective", CLIN EXP RH, 19(6), 2001, pp. S23-S30
73. Abramson, SB; Furst, DE; Hochberg, MC; Patrono, C
    Controversies in COX-2 inhibitor therapy: Closing remarks
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    S.B. Abramson et al., "Controversies in COX-2 inhibitor therapy: Closing remarks", CLIN EXP RH, 19(6), 2001, pp. S77-S80
74. Huskisson, EC
    Nimesulide, a balanced drug for the treatment of osteoarthritis
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    E.C. Huskisson, "Nimesulide, a balanced drug for the treatment of osteoarthritis", CLIN EXP RH, 19(1), 2001, pp. S21-S25
75. Diez, JJ; Iglesias, P; Gomez-Pan, A
    Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    
    J.J. Diez et al., "Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide", J ENDOC INV, 24(5), 2001, pp. 303-309
76. Attanasio, R; Barausse, M; Cozzi, R
    GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    
    R. Attanasio et al., "GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide", J ENDOC INV, 24(4), 2001, pp. 209-216
77. Pelissier, C; de Kervasdoue, A; Chuong, VT; Maugis, EL; de Mouillac, FV; Breil, MH; Moniot, G; Zeitoun-Lepvrier, G; Robin, M; Rime, B
    Clinical evaluation, dose-finding and acceptability of AERODIOL (R), the pulsed estrogen therapy for treatment of climacteric symptoms
    MATURITAS
    
    C. Pelissier et al., "Clinical evaluation, dose-finding and acceptability of AERODIOL (R), the pulsed estrogen therapy for treatment of climacteric symptoms", MATURITAS, 37(3), 2001, pp. 181-189
78. 
    Levetiracetam - Keppra (R) - Antiepileptic
    DRUGS OF THE FUTURE
    
    DRUG FUTURE, 26(2), 2001, pp. 182-184
79. Dingemanse, J; Pedrazzetti, E; van Giersbergen, PLM
    Multiple-dose tolerability, pharmacodynamics, and pharmacokinetics of the quinolizinone hypnotic Ro 41-3696 in elderly subjects
    CLINICAL NEUROPHARMACOLOGY
    
    J. Dingemanse et al., "Multiple-dose tolerability, pharmacodynamics, and pharmacokinetics of the quinolizinone hypnotic Ro 41-3696 in elderly subjects", CLIN NEUROP, 24(2), 2001, pp. 82-90
80. Sauerbrey-Wullkopf, N; Kupper, W
    Amlodipine versus sustained release nifedipine: Randomized, double-blind comparative study to investigate long-term efficacy and safety of amlodipineversus sustained release nifedipine in the monotreatment of chronic stableangina pectoris
    HERZ
    
    N. Sauerbrey-Wullkopf e W. Kupper, "Amlodipine versus sustained release nifedipine: Randomized, double-blind comparative study to investigate long-term efficacy and safety of amlodipineversus sustained release nifedipine in the monotreatment of chronic stableangina pectoris", HERZ, 26(2), 2001, pp. 149-156
81. Devuyst, G; Bogousslavsky, J
    Update on recent progress in drug treatment for acute ischemic stroke
    JOURNAL OF NEUROLOGY
    
    G. Devuyst e J. Bogousslavsky, "Update on recent progress in drug treatment for acute ischemic stroke", J NEUROL, 248(9), 2001, pp. 735-742
82. Watelet, JB; Vermeiren, J; Van Cauwenberge, P
    Efficacy of intranasal treatment in children with rhinitis allergy.
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    
    J.B. Watelet et al., "Efficacy of intranasal treatment in children with rhinitis allergy.", REV FR ALLE, 41(7), 2001, pp. 628-633
83. Diener, HC; Louis, P; Schellens, R; De Beukelaar, F
    Treatment of migraine attacks with intranasal alniditan: an open study
    CEPHALALGIA
    
    H.C. Diener et al., "Treatment of migraine attacks with intranasal alniditan: an open study", CEPHALALGIA, 21(2), 2001, pp. 140-144
84. Kelkar, PS; Butterfield, JH; Teaford, HG
    Urticaria and angioedema from cyclooxygenase-2 inhibitors
    JOURNAL OF RHEUMATOLOGY
    
    P.S. Kelkar et al., "Urticaria and angioedema from cyclooxygenase-2 inhibitors", J RHEUMATOL, 28(11), 2001, pp. 2553-2554
85. Berube-Parent, S; Prud'homme, D; St-Pierre, S; Doucet, E; Tremblay, A
    Obesity treatment with a progressive clinical tri-therapy combining sibutramine and a supervised diet-exercise intervention
    INTERNATIONAL JOURNAL OF OBESITY
    
    S. Berube-Parent et al., "Obesity treatment with a progressive clinical tri-therapy combining sibutramine and a supervised diet-exercise intervention", INT J OBES, 25(8), 2001, pp. 1144-1153
86. Fanghanel, G; Cortinas, L; Sanchez-Reyes, L; Berber, A
    Second phase of a double-blind study clinical trial on Sibutramine for thetreatment of patients suffering essential obesity: 6 months after treatment cross-over
    INTERNATIONAL JOURNAL OF OBESITY
    
    G. Fanghanel et al., "Second phase of a double-blind study clinical trial on Sibutramine for thetreatment of patients suffering essential obesity: 6 months after treatment cross-over", INT J OBES, 25(5), 2001, pp. 741-747
87. Hauner, H
    Current pharmacological approaches to the treatment of obesity
    INTERNATIONAL JOURNAL OF OBESITY
    
    H. Hauner, "Current pharmacological approaches to the treatment of obesity", INT J OBES, 25, 2001, pp. S102-S106
88. Michel, MC; Bressel, HU; Goepel, M; Rubben, H
    A 6-month large-scale study into the safety of tamsulosin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    M.C. Michel et al., "A 6-month large-scale study into the safety of tamsulosin", BR J CL PH, 51(6), 2001, pp. 609-614
89. Speakman, MJ
    Lower urinary tract symptoms suggestive of benign prostatic obstruction: What is the available evidence for rational management?
    EUROPEAN UROLOGY
    
    M.J. Speakman, "Lower urinary tract symptoms suggestive of benign prostatic obstruction: What is the available evidence for rational management?", EUR UROL, 39, 2001, pp. 6-12
90. Sijpkens, YWJ; Mallat, MJK; Siegert, CEH; Zwinderman, AH; Westendorp, RGJ; de Fijter, JW; van Es, LA; Paul, LC
    Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral
    CLINICAL NEPHROLOGY
    
    Y.W.J. Sijpkens et al., "Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral", CLIN NEPHR, 55(2), 2001, pp. 149-155
91. McKenna, F; Borenstein, D; Wendt, H; Wallemark, C; Lefkowith, JB; Geis, GS
    Celecoxib versus diclofenac in the management of osteoarthritis of the knee - A placebo-controlled, randomised, double-blind comparison
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    
    F. McKenna et al., "Celecoxib versus diclofenac in the management of osteoarthritis of the knee - A placebo-controlled, randomised, double-blind comparison", SC J RHEUM, 30(1), 2001, pp. 11-18
92. Acevedo, E; Castaneda, O; Ugaz, M; Beaulieu, AD; Pons-Estel, B; Caeiro, F; Casas, N; Garza-Elizondo, M; Irazoque, F; Hinojosa, W; Gutierrez-Urena, S; Vandormael, K; Rodgers, DB; Laurenzi, M
    Tolerability profiles of rofecoxib (Vioxx (R)) and Arthrotoc (R) - A comparison of six weeks treatment in patients with osteoarthritis
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    
    E. Acevedo et al., "Tolerability profiles of rofecoxib (Vioxx (R)) and Arthrotoc (R) - A comparison of six weeks treatment in patients with osteoarthritis", SC J RHEUM, 30(1), 2001, pp. 19-24
93. van der Does, R; Euler, R
    A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    R. van der Does e R. Euler, "A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension", J INT MED R, 29(3), 2001, pp. 154-162
94. Tsutsui, S
    A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    S. Tsutsui, "A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia", J INT MED R, 29(3), 2001, pp. 163-177
95. Hovinga, CA
    Levetiracetam: A novel antiepileptic drug
    PHARMACOTHERAPY
    
    C.A. Hovinga, "Levetiracetam: A novel antiepileptic drug", PHARMACOTHE, 21(11), 2001, pp. 1375-1388
96. Koran, LM; Quirk, T; Lorberbaum, JP; Elliott, M
    Mirtazapine treatment of obsessive-compulsive disorder
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    L.M. Koran et al., "Mirtazapine treatment of obsessive-compulsive disorder", J CL PSYCH, 21(5), 2001, pp. 537-539
97. Guelfi, JD; Ansseau, M; Timmerman, L; Korsgaard, S
    Mirtazapine versus venlafaxine in hospitalized severely depressed patientswith melancholic features
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    J.D. Guelfi et al., "Mirtazapine versus venlafaxine in hospitalized severely depressed patientswith melancholic features", J CL PSYCH, 21(4), 2001, pp. 425-431
98. Hellerstein, DJ; Batchelder, S; Kreditor, D; Fedak, M
    Bupropion sustained-release for the treatment of dysthymic disorder: An open-label study
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    D.J. Hellerstein et al., "Bupropion sustained-release for the treatment of dysthymic disorder: An open-label study", J CL PSYCH, 21(3), 2001, pp. 325-329
99. Zaninelli, R; Bauer, M; Jobert, M; Muller-Oerlinghausen, B
    Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    R. Zaninelli et al., "Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline", J CL PSYCH, 21(2), 2001, pp. 190-198
100. Raffa, RB
     Pharmacology of oral combination analgesics: rational therapy for pain
     JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
     
     R.B. Raffa, "Pharmacology of oral combination analgesics: rational therapy for pain", J CLIN PH T, 26(4), 2001, pp. 257-264